key advancements in the treatment of bpdcn from ebmt 2024
Published 2 months ago • 39 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
2:37
recent advances in the treatment of bpdcn & the long-term benefits of tagraxofusp
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
1:41
improvements in the awareness and diagnosis of bpdcn
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:18:13
b cell profiling with elispot and fluorospot
-
1:06:04
itp: novel treatments
-
32:56
echo analyzer monthly maintenance
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
2:20
ebmt diagnostic criteria for tma post-allosct and the role of complement activation
-
35:13
advances in the diagnosis and treatment of bpdcn – dr. naveen pemmaraju (may 26-27, 2023)
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
2:49
transplantation today: what are the key messages
-
0:47
overview of the phase iii enhance trial schema
-
3:34
clofarabine preconditioning followed by allogeneic transplantation with tbi & ptcy for r/r aml
-
3:57
key messages from bsh administration of blood components guideline
-
2:02
genpath oncology
-
0:59
versatility of toshiba’s infinix system works as a hybrid suite
-
2:20
bioivt overview - biospecimen solutions and research services